Decision-making for Precision Oncology in Advanced Prostate Cancer
This study is for veterans with advanced prostate cancer (cancer that has spread). It aims to understand and improve how patients make decisions about precision oncology. Precision oncology uses genetic and tumor tests to guide cancer treatment. The study will use online surveys and a mobile app to help patients make informed choices. Researchers want to see if these tools can reduce decisional conflict, which is when you feel unsure about a medical decision. You might be able to join if you are 18 or older, can understand English, and are able to complete study procedures. The study plans to enroll 250 participants, but its current status is unclear.
- Study design
- This interventional study aims to enroll 250 participants. It is not specified if it is randomized or blinded.
- What's involved
- You would complete online surveys after appointments and use a mobile application on your device. The study may last up to 3 years.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your decisional conflict will be measured at 6 months. Enrollment will be tracked for up to 3 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Daniel Kwon, MD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Mean score on the Decisional Conflict Scale (DCS) (Stage 1)6 months
The Decisional Conflict Scale measures personal perceptions of : a) uncertainty in choosing options; b) modifiable factors contributing to uncertainty such as feeling uninformed, unclear about personal values and unsupported in decision making; and c) effective decision making such as feeling the choice is informed, values-based, likely to be implemented and expressing satisfaction with the choice. Scoring and interpretation Items are given a score value ranging from 0 = 'strongly disagree' to 4 = 'strongly agree'. Total Scores are a sum of the scores of the 16 items and are scaled by divided by 16 and then multiplied by 25 for a total scale score range from 0 \[extremely high decisional conflict\] to 100 \[no decisional conflict\]. Mean score and 95% confidence interval (CI) of the total DCS as well as the 4 subscales will be calculated.
- Proportion of participants with a total score of >37.5 on the DCS (Stage 1)6 months
Participants who completed the DCS will be divided by their total score into those who scored \>37.5 or not. The proportion of participants with a total score of \> 37.5 will be reported.
- Proportion of participants enrolled (Stage 3)Up to 3 years
The proportion of invited participants who consent to the study compared to the total number of participants approached will be reported as measured by study entry.
- Proportion of participants providing reason for not enrolling (Stage 3)Up to 3 years
The proportion of invited participants who do not consent to the study will have the reason for not joining recorded and totaled.